UBS Reaffirms Their Hold Rating on Salesforce (CRM)
In a report released today, Karl Keirstead from UBS maintained a Hold rating on Salesforce (CRM – Research Report), with a price target of $320.00. The company's shares closed today at $288.06.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Keirstead covers the Technology sector, focusing on stocks such as Microsoft, Adobe, and ServiceNow. According to TipRanks, Keirstead has an average return of 14.6% and a 65.12% success rate on recommended stocks.
In addition to UBS, Salesforce also received a Hold from Monness's Brian White in a report issued yesterday. However, on the same day, Citizens JMP reiterated a Buy rating on Salesforce (NYSE: CRM).
The company has a one-year high of $369.00 and a one-year low of $212.00. Currently, Salesforce has an average volume of 6.97M.
Based on the recent corporate insider activity of 241 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CRM in relation to earlier this year. Last month, R DAVID SCHMAIER, the Chief Product & Impact Officer of CRM sold 6,959.00 shares for a total of $1,762,714.70.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)
In a report released today, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva (TEVA – Research Report), with a price target of ILA9,300.00. The company's shares closed last Thursday at ILA6,205.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Levi is an analyst with an average return of -5.7% and a 0.00% success rate. Teva has an analyst consensus of Hold. TEVA market cap is currently ILs69.87B and has a P/E ratio of -14.31.
Yahoo
an hour ago
- Yahoo
UBS bank challenges proposed capital requirement increases
UBS banking group has mostly accepted regulatory proposals issued by the Swiss government but on Friday argued against an increase in capital requirements. The measures from the Federal Council "would result in capital requirements that are neither proportionate nor internationally aligned," the bank said. The new proposals would require UBS to fully deduct investments in foreign subsidiaries, deferred tax assets on temporary differences, and capitalized software from its CET1 capital, alongside increased prudential valuation adjustments. UBS noted that the changes would force the company to hold an estimated additional $24 billion in CET1 capital, primarily due to a $23 billion deduction of its foreign subsidiaries' investments. At the group level, the CET1 capital ratio would rise to 19%, but regulatory measures misaligned with global standards could reduce it to around 17%, underrepresenting UBS's financial strength. The capital requirement increase would come on top of $18 billion already needed following UBS's acquisition of Credit Suisse-bringing the total additional CET1 capital required to $42 billion. Despite these proposed regulations, UBS Group AG maintains its target of a 15% underlying return on CET1 capital and a cost/income ratio below 70% by the end of 2026. UBS reaffirms its 2025 capital return plans, including a 10% dividend increase and share repurchases of up to $3 billion, contingent on maintaining its CET1 capital ratio target of 14%. Future capital return goals for 2026 will be disclosed with its fourth-quarter and full-year financial results for 2025. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
UBS Lifts Kingsoft Cloud Holdings Limited (KC) to $14 Amid AI Growth
On Thursday, UBS analysts raised the price target for Kingsoft Cloud Holdings Limited (NASDAQ:KC) while maintaining a "Buy" rating. This confidence is attributed to the company's position as a pure-play cloud vendor with huge AI potential, anticipated to increase to over 40% by 2027, in contrast to 17% of total revenue in 2024. An executive standing in front of their headquarters building, proudly symbolizing the company's achievements. A fascinating development is the anticipated rebound in the company's public cloud segment, which is projected to achieve a 20% revenue compound annual growth rate (CAGR) by 2027. From the climbing demand for AI-powered cloud solutions, greater contributions from Xiaomi's ecosystem, and sustained growth in external clients, the reasons that explain this surge are many. Analysts also anticipate that Kingsoft Cloud Holdings Limited's (NASDAQ:KC) non-GAAP operating margin will improve, with narrow losses expected until achieving profitability by 2027. This strengthened standing is driven by higher revenue dependence on AI and enhanced cost efficiency from scaling operations. Indeed, it's AI that is backing the analysts' bullish stance. Kingsoft Cloud Holdings Limited (NASDAQ:KC) is a Chinese cloud service provider that offers cloud solutions, research and development services, enterprise digital solutions, and related services. Founded in 2012, the company aims to become clients' trusted partners and capitalize on digitalization. While we acknowledge the potential of KC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
